BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 27, 2022
View Archived Issues
Ginisortamab restores gremlin-1-ablated BMP signaling in CRC cell lines
Read More
Novel murine model may shed light for future strategies for aggressive glioblastoma
Read More
Servier patents new MAT2A inhibitors
Read More
Sumitomo Pharma divulges Chk1 inhibitors
Read More
Anti-HER2 domain-specific antibody-drug radioconjugates show promise in models of breast cancer
Read More
SAGE Therapeutics describes new GABA-A receptor modulators
Read More
Merck & Co. identifies new GLCT-1 inhibitors
Read More
Tokyo University of Science discloses LXR antagonists
Read More
Silo in commercial evaluation license agreement for next-generation liposomes for autoimmune disease
Read More
Dual CXCR4/ACKR3 inhibitor in combination with ICT impedes 4T1 tumor growth and metastasis
Read More
FDA clears Fusion's IND applications for FPI-2059 and imaging analogue FPI-2058
Read More
[89Zr]-Labeled antibody targeting glypican-1 developed as theranostic for pancreatic cancer
Read More
First preclinical data on NR2F6 antagonist TES-4207
Read More
Molecular signature predicts cancer risk in patients with NAFLD
Read More
Voltron initiates preclinical study of vaccine candidate VTX-067 in immune-oncology model
Read More
SAN-903 dampens renal fibrosis in mouse model of chronic kidney disease
Read More
Evaxion to advance EVX-03 into clinic for NSCLC
Read More
Brilacidin inhibits Omicron, Delta, Gamma and Alpha SARS-CoV-2 variants in vitro
Read More
Soligenix reports 100% protection in NHPs with bivalent vaccine against MARV and SUDV
Read More
